Pathogenesis of Liver Fibrosis
The DOI matches its Crossref record; 220 of the 222 references it cites were found in a registry or an index, and 2 are not checked yet.
Abstract
Liver fibrosis is a major cause of morbidity and mortality worldwide due to chronic viral hepatitis and, more recently, from fatty liver disease associated with obesity. Hepatic stellate cell activation represents a critical event in fibrosis because these cells become the primary source of extracellular matrix in liver upon injury. Use of cell-culture and animal models has expanded our understanding of the mechanisms underlying stellate cell activation and has shed new light on genetic regulation, the contribution of immune signaling, and the potential reversibility of the disease. As pathways of fibrogenesis are increasingly clarified, the key challenge will be translating new advances into the development of antifibrotic therapies for patients with chronic liver disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“STAT3, a member of the STATs family, is a key transcriptional mediator of cellular processes [43, 44].”
From Saikosaponin b1 Attenuates Liver Fibrosis by Blocking STAT3/Gli1 Interaction and Inducing Gli1 Degradation (2025) · cites this paper as [43]
In the citing paper
“they may also derive from portal fibroblasts, bone marrow-derived cells, circulating fibrocytes, [7] and by the controversially discussed epithelial-tomesenchymal (EMT) [8,9] or endothelial-to-mesenchymal (EndoTM) transition.[10,11]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [7]
Citations
Cites
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
El–Serag, H. B., & Rudolph, K. L. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.061 · Cited by 5,415
Origins and Mechanisms of miRNAs and siRNAs
Carthew, R. W., & Sontheimer, E. J. (2009) · Cell · doi:10.1016/j.cell.2009.01.035 · Cited by 5,018
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842
Self-citationMany roads to maturity: microRNA biogenesis pathways and their regulation
Winter, J., Jung, S., Keller, S., Gregory, R. I., & Diederichs, S. (2009) · Nature Cell Biology · doi:10.1038/ncb0309-228 · Cited by 2,656
Epithelial-mesenchymal transition and its implications for fibrosis
Kalluri, R., & Neilson, E. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320530 · Cited by 2,649
Mechanisms of Hepatic Fibrogenesis
Friedman, S. L. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.003 · Cited by 2,634
Self-citationEndothelial-to-mesenchymal transition contributes to cardiac fibrosis
Zeisberg, E. M., Tarnavski, O., Zeisberg, M., Dorfman, A. L., McMullen, J. R., Gustafsson, E., Chandraker, A., Yuan, X., Pu, W. T., Roberts, A. B., et al. (2007) · Nature Medicine · doi:10.1038/nm1613 · Cited by 2,222
Bendelac, A., Savage, P. B., & Teyton, L. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141711 · Cited by 2,155
Research works printed but not linked: 15
- 10.1172/jci200112373 · DOI · Paper page
- 10.1055/s-2001-17556 · DOI · Paper page
- Stupack DG., 2007, Oncology, 21, 6
- Hehlgans S, 2007, Biochim. Biophys. Acta, 1775, 163
- Omenetti A, 2008, J. Clin. Investig., 118, 3331
- Pinzani M, 1996, Am. J. Pathol., 148, 785
- Sims DE., 1991, Can. J. Cardiol., 7, 431
- Thimgan MS, 1999, Am. J. Physiol., 277, G137
- 10.1136/gut.2005.088690 · DOI · Paper page
- Gao B., 2005, Cell Mol. Immunol., 2, 92
- Anania FA, 1995, Hepatology, 21, 1640
- Connolly MK, 2009, J. Clin. Investig., 119, 3213
- Seki E, 2009, J. Clin. Investig., 119, 1858
- McCrudden R, 2000, Histol. Histopathol., 15, 1159
- 10.1002/hep.23046 · DOI · Paper page
Cited by
Resolving the fibrotic niche of human liver cirrhosis at single-cell level
Ramachandran, P., Dobie, R., Wilson-Kanamori, J. R., Dora, E. F., Henderson, B. E. P., Luu, N. T., Portman, J. R., Matchett, K. P., Brice, M., Marwick, J. A., et al. (2019) · Nature · doi:10.1038/s41586-019-1631-3 · Cited by 1,784
TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis—Updated 2019
Dewidar, B., Meyer, C., Dooley, S., & Meindl-Beinker, A. N. (2019) · Cells · doi:10.3390/cells8111419 · Cited by 837
“Fibrosis means that an excessive amount of fibrillar extracellular matrix (ECM) proteins, e.g., collagen I and III, is deposited in the space of Disse [1,2].”
BackgroundThe myofibroblast matrix: implications for tissue repair and fibrosis
Klingberg, F., Hinz, B., & White, E. S. (2013) · The Journal of Pathology · doi:10.1002/path.4104 · Cited by 776
The crucial roles of inflammatory mediators in inflammation: A review
Abdulkhaleq, L. A., Assi, M. A., Abdullah, R., Zamri-Saad, M., Taufiq-Yap, Y. H., & Hezmee, M. N. M. (2018) · Veterinary World · doi:10.14202/vetworld.2018.627-635 · Cited by 775
The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer
Affo, S., Yu, L.-X., & Schwabe, R. F. (2017) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-052016-100322 · Cited by 757
Kou, M., Huang, L., Yang, J., Chiang, Z., Chen, S., Liu, J., Guo, L., Zhang, X., Zhou, X., Xu, X., et al. (2022) · Cell Death & Disease · doi:10.1038/s41419-022-05034-x · Cited by 640
“Liver fibrosis is a pathophysiological process and refers to the abnormal proliferation of intrahepatic connective tissue due to various pathogenic factors [125].”
BackgroundAdiponectin regulation and function
Fang, H., & Judd, R. L. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170046 · Cited by 631
“Activated HSCs are proliferative and play a central role in the development of fibrosis by secreting collagen and other ECMs and releasing chemotactic factors that recruit immune cells to the injury site (100) (Fig.”
A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response
Ding, N., Yu, R. T., Subramaniam, N., Sherman, M. H., Wilson, C., Rao, R., Leblanc, M., Coulter, S., He, M., Scott, C., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.028 · Cited by 622
Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum
Hardy, T., Oakley, F., Anstee, Q. M., & Day, C. P. (2016) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044224 · Cited by 611
MicroRNA-21 Promotes Fibrosis of the Kidney by Silencing Metabolic Pathways
Chau, B. N., Xin, C., Hartner, J., Ren, S., Castano, A. P., Linn, G., Li, J., Tran, P. T., Kaimal, V., Huang, X., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003205 · Cited by 587
High-yield and high-purity isolation of hepatic stellate cells from normal and fibrotic mouse livers
Mederacke, I., Dapito, D. H., Affò, S., Uchinami, H., & Schwabe, R. F. (2015) · Nature Protocols · doi:10.1038/nprot.2015.017 · Cited by 549
The good and the bad collagens of fibrosis – Their role in signaling and organ function
Karsdal, M. A., Nielsen, S. H., Leeming, D. J., Langholm, L. L., Nielsen, M. J., Manon-Jensen, T., Siebuhr, A., Gudmann, N. S., Rønnow, S., Sand, J. M., et al. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.07.014 · Cited by 509
Matrix metalloproteinases in liver injury, repair and fibrosis
Duarte, S., Baber, J., Fujii, T., & Coito, A. J. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.01.004 · Cited by 476
Mechanisms of liver fibrosis and its role in liver cancer
Dhar, D., Baglieri, J., Kisseleva, T., & Brenner, D. A. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370219898141 · Cited by 429
“Morphologically, liver fibrosis is characterized by accumulation of extracellular matrix (ECM), followed by formation of fibrous scar and subsequent cirrhosis which is defined by the presence of nodules of regenerating hepatocytes with decreased blood supply to the liver.(2,3) Hepatic stellate cells (HSCs) are the mai…”
BackgroundDulauroy, S., Di Carlo, S. E., Langa, F., Eberl, G., & Peduto, L. (2012) · Nature Medicine · doi:10.1038/nm.2848 · Cited by 418
Liver macrophages in health and disease
Guilliams, M., & Scott, C. L. (2022) · Immunity · doi:10.1016/j.immuni.2022.08.002 · Cited by 395
Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update
Elpek, G. Ö. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i23.7260 · Cited by 382
Lipid nanoparticle technology for therapeutic gene regulation in the liver
Witzigmann, D., Kulkarni, J. A., Leung, J., Chen, S., Cullis, P. R., & van der Meel, R. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.026 · Cited by 376
“This pathophysiological process dramatically impairs the transendothelial transport of any substance from the systemic circulation to hepatocytes with major implications for nanoparticle-based nucleic acid therapeutics [74,75].”
Zhang, Z., Lin, H., Shi, M., Xu, R., Fu, J., Lv, J., Chen, L., Lv, S., Li, Y., Yu, S., et al. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.07024.x · Cited by 372
Lichtinghagen, R., Pietsch, D., Bantel, H., Manns, M. P., Brand, K., & Bahr, M. J. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.03.016 · Cited by 370
Paired-cell sequencing enables spatial gene expression mapping of liver endothelial cells
Halpern, K. B., Shenhav, R., Massalha, H., Toth, B., Egozi, A., Massasa, E. E., Medgalia, C., David, E., Giladi, A., Moor, A. E., et al. (2018) · Nature Biotechnology · doi:10.1038/nbt.4231 · Cited by 368
Hrd1 suppresses Nrf2-mediated cellular protection during liver cirrhosis
Wu, T., Zhao, F., Gao, B., Tan, C., Yagishita, N., Nakajima, T., Wong, P. K., Chapman, E., Fang, D., & Zhang, D. D. (2014) · Genes & Development · doi:10.1101/gad.238246.114 · Cited by 353
Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis
Fabregat, I., & Caballero-Díaz, D. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00357 · Cited by 351
“fibrogenic MFB are endogenous and their origin is controversial and still unclear, but nowadays there are accepted different sources (63–65), among them, portal and resident fibroblasts (66), activation and differentiation of HSC (more details in the next section) (16, 67), bone marrow-derived fibrocytes (68), liver e…”
BackgroundBaglieri, J., Brenner, D. A., & Kisseleva, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071723 · Cited by 341
“Morphologically, liver fibrosis is characterized by the accumulation of ECM, followed by the formation of fibrous scar and subsequent cirrhosis [19,20].”
BackgroundPyroptosis in health and disease: mechanisms, regulation and clinical perspective
Liu, Y., Pan, R., Ouyang, Y., Gu, W., Xiao, T., Yang, H., Tang, L., Wang, H., Xiang, B., & Chen, P. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01958-2 · Cited by 337
Liedtke, C., Luedde, T., Sauerbruch, T., Scholten, D., Streetz, K., Tacke, F., Tolba, R., Trautwein, C., Trebicka, J., & Weiskirchen, R. (2013) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-6-19 · Cited by 335
Nanoparticles' interactions with vasculature in diseases
Tee, J. K., Yip, L. X., Tan, E. S., Santitewagun, S., Prasath, A., Ke, P. C., Ho, H. K., & Leong, D. T. (2019) · Chemical Society Reviews · doi:10.1039/c9cs00309f · Cited by 314
An AMPK–caspase-6 axis controls liver damage in nonalcoholic steatohepatitis
Zhao, P., Sun, X., Chaggan, C., Liao, Z., in Wong, K., He, F., Singh, S., Loomba, R., Karin, M., Witztum, J. L., et al. (2020) · Science · doi:10.1126/science.aay0542 · Cited by 307
Recent advancement of molecular mechanisms of liver fibrosis
Seki, E., & Brenner, D. A. (2015) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1002/jhbp.245 · Cited by 300
Inflammation in Alcoholic Liver Disease
Wang, H. J., Gao, B., Zakhari, S., & Nagy, L. E. (2012) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-072610-145138 · Cited by 297
Trépo, E., Romeo, S., Zucman-Rossi, J., & Nahon, P. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.03.011 · Cited by 291
Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis
Li, J. Z., Huang, Y., Karaman, R., Ivanova, P. T., Brown, H. A., Roddy, T., Castro-Perez, J., Cohen, J. C., & Hobbs, H. H. (2012) · Journal of Clinical Investigation · doi:10.1172/jci65179 · Cited by 283
“The mRNA levels of Tnfa, Col1a1, and Acta2, which are increased in association with hepatic inflammation and fibrosis (43), were not increased in these animals.”
Hepatic MR Elastography: Clinical Performance in a Series of 1377 Consecutive Examinations
Yin, M., Glaser, K. J., Talwalkar, J. A., Chen, J., Manduca, A., & Ehman, R. L. (2016) · Radiology · doi:10.1148/radiol.2015142141 · Cited by 276
Nrf2 promotes the development of fibrosis and tumorigenesis in mice with defective hepatic autophagy
Ni, H.-M., Woolbright, B. L., Williams, J., Copple, B., Cui, W., Luyendyk, J. P., Jaeschke, H., & Ding, W.-X. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.04.043 · Cited by 270
Fisher, F. M., Chui, P. C., Nasser, I. A., Popov, Y., Cunniff, J. C., Lundasen, T., Kharitonenkov, A., Schuppan, D., Flier, J. S., & Maratos-Flier, E. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.07.044 · Cited by 263
Kim, K.-H., Chen, C.-C., Monzon, R. I., & Lau, L. F. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00049-13 · Cited by 261
Single-cell technologies in hepatology: new insights into liver biology and disease pathogenesis
Ramachandran, P., Matchett, K. P., Dobie, R., Wilson-Kanamori, J. R., & Henderson, N. C. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0304-x · Cited by 253
Bosch, J., Groszmann, R. J., & Shah, V. H. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.01.003 · Cited by 252
Jiang, J. X., Chen, X., Serizawa, N., Szyndralewiez, C., Page, P., Schröder, K., Brandes, R. P., Devaraj, S., & Török, N. J. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.05.007 · Cited by 251
Yang, W., He, H., Wang, T., Su, N., Zhang, F., Jiang, K., Zhu, J., Zhang, C., Niu, K., Wang, L., et al. (2021) · Hepatology · doi:10.1002/hep.31987 · Cited by 250
“Liver fibrosis is characterized by the emergence of myofibroblasts, which produce excessive extracellular matrix, resulting in the progressive loss of liver microstructure and metabolic function and eventual liver failure (3).”
BackgroundMolecular pathogenesis of hepatic fibrosis and current therapeutic approaches
Mormone, E., George, J., & Nieto, N. (2011) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2011.07.001 · Cited by 246
Rao, J., Wang, H., Ni, M., Wang, Z., Wang, Z., Wei, S., Liu, M., Wang, P., Qiu, J., Zhang, L., et al. (2022) · Gut · doi:10.1136/gutjnl-2021-325150 · Cited by 241
Tanwar, S., Rhodes, F., Srivastava, A., Trembling, P. M., & Rosenberg, W. M. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i2.109 · Cited by 241
Duran, A., Hernandez, E. D., Reina-Campos, M., Castilla, E. A., Subramaniam, S., Raghunandan, S., Roberts, L. R., Kisseleva, T., Karin, M., Diaz-Meco, M. T., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.09.004 · Cited by 239
Verbeke, L., Mannaerts, I., Schierwagen, R., Govaere, O., Klein, S., Vander Elst, I., Windmolders, P., Farre, R., Wenes, M., Mazzone, M., et al. (2016) · Scientific Reports · doi:10.1038/srep33453 · Cited by 236
Coll, M., Perea, L., Boon, R., Leite, S. B., Vallverdú, J., Mannaerts, I., Smout, A., El Taghdouini, A., Blaya, D., Rodrigo-Torres, D., et al. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.05.027 · Cited by 233
“If injury persists, activated HSCs increase the production of ECM components and reduce degradation, becoming the main fibrogenic cell type of the liver (Hernandez-Gea and Friedman, 2011; Mederacke et al., 2013).”
The commonly used antimicrobial additive triclosan is a liver tumor promoter
Yueh, M.-F., Taniguchi, K., Chen, S., Evans, R. M., Hammock, B. D., Karin, M., & Tukey, R. H. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1419119111 · Cited by 228
Coulouarn, C., Corlu, A., Glaise, D., Guénon, I., Thorgeirsson, S. S., & Clément, B. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3317 · Cited by 224
Wang, R., Ding, Q., Yaqoob, U., de Assuncao, T. M., Verma, V. K., Hirsova, P., Cao, S., Mukhopadhyay, D., Huebert, R. C., & Shah, V. H. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.671735 · Cited by 222
Verma, V. K., Li, H., Wang, R., Hirsova, P., Mushref, M., Liu, Y., Cao, S., Contreras, P. C., Malhi, H., Kamath, P. S., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.020 · Cited by 221
“This inflammatory response parallels the extent of injury and fibrosis [40].”
Traber, P. G., Chou, H., Zomer, E., Hong, F., Klyosov, A., Fiel, M.-I., & Friedman, S. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075361 · Cited by 214
Self-citationSeubert, B., Grünwald, B., Kobuch, J., Cui, H., Schelter, F., Schaten, S., Siveke, J. T., Lim, N. H., Nagase, H., Simonavicius, N., et al. (2015) · Hepatology · doi:10.1002/hep.27378 · Cited by 213
Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosis
Mallat, A., & Lotersztajn, S. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00230.2013 · Cited by 211
BRD4 is a novel therapeutic target for liver fibrosis
Ding, N., Hah, N., Yu, R. T., Sherman, M. H., Benner, C., Leblanc, M., He, M., Liddle, C., Downes, M., & Evans, R. M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522163112 · Cited by 211
Smoothened is a master regulator of adult liver repair
Michelotti, G. A., Xie, G., Swiderska, M., Choi, S. S., Karaca, G., Krüger, L., Premont, R., Yang, L., Syn, W.-K., Metzger, D., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66904 · Cited by 208
“Both approaches confirmed the immunohistochemistry data, with all assays showing that at least one-quarter of hepatocytes were derived from α SMA-express-ing cells (range 24%–34%, Figure 6, B and C, and Supplemental Figure 14), thus supporting the hypothesis that Hh-responsive MF populations include precursors of adul…”
InfluentialTherapy of Experimental NASH and Fibrosis with Galectin Inhibitors
Traber, P. G., & Zomer, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083481 · Cited by 208
Update on hepatic stellate cells: pathogenic role in liver fibrosis and novel isolation techniques
Tacke, F., & Weiskirchen, R. (2012) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.11.92 · Cited by 205
Neutralization of Oxidized Phospholipids Ameliorates Non-alcoholic Steatohepatitis
Sun, X., Seidman, J. S., Zhao, P., Troutman, T. D., Spann, N. J., Que, X., Zhou, F., Liao, Z., Pasillas, M., Yang, X., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2019.10.014 · Cited by 204
“Typically, NASH is accompanied by hepatocellular ballooning, varying degrees of pericellular fibrosis and elevated serum transaminase levels (Friedman et al., 2018; Hernandez-Gea and Friedman, 2011).”
BackgroundKornek, M., Lynch, M., Mehta, S. H., Lai, M., Exley, M., Afdhal, N. H., & Schuppan, D. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.04.031 · Cited by 203
PM2.5 induces liver fibrosis via triggering ROS-mediated mitophagy
Qiu, Y.-N., Wang, G.-H., Zhou, F., Hao, J.-J., Tian, L., Guan, L.-F., Geng, X.-K., Ding, Y.-C., Wu, H.-W., & Zhang, K.-Z. (2019) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2018.08.050 · Cited by 198
Vitamin D in chronic liver disease
Stokes, C. S., Volmer, D. A., Grünhage, F., & Lammert, F. (2013) · Liver International · doi:10.1111/liv.12106 · Cited by 194
The role of growth hormone and insulin-like growth factor-I in the liver
Takahashi, Y. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071447 · Cited by 193
HCV and HIV co-infection: mechanisms and management
Chen, J. Y., Feeney, E. R., & Chung, R. T. (2014) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2014.17 · Cited by 193
Shan, C., Wang, R., Wang, S., Zhang, Z., Xing, C., Feng, W., Zhao, Z., Zhou, S., Zhao, A. Z., Mu, Y., et al. (2021) · Experimental Physiology · doi:10.1113/ep089328 · Cited by 192
“Activation of resident HSCs and subsequent trans-differentiation into myofibroblasts play key roles in liver fibrosis, and have been accepted as a major target for anti-fibrotic therapy (Hernandez-Gea & Friedman, 2011; Seki & Brenner, 2015; Wynn, 2008).”
BackgroundAkkız, H., Gieseler, R. K., & Canbay, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147873 · Cited by 191
Drug targeting to myofibroblasts: Implications for fibrosis and cancer
Yazdani, S., Bansal, R., & Prakash, J. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.07.010 · Cited by 189
Mu, M., Zuo, S., Wu, R.-M., Deng, K.-S., Lu, S., Zhu, J.-J., Zou, G.-L., Yang, J., Cheng, M.-L., & Zhao, X.-K. (2018) · Drug Design, Development and Therapy · doi:10.2147/dddt.s186726 · Cited by 186
Liver fibrosis: mechanisms of immune-mediated liver injury
Xu, R., Zhang, Z., & Wang, F.-S. (2012) · Cellular & Molecular Immunology · doi:10.1038/cmi.2011.53 · Cited by 183
Böttcher, K., & Pinzani, M. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.05.016 · Cited by 182
Devhare, P. B., Sasaki, R., Shrivastava, S., Di Bisceglie, A. M., Ray, R., & Ray, R. B. (2017) · Journal of Virology · doi:10.1128/jvi.02225-16 · Cited by 182
Zeybel, M., Hardy, T., Robinson, S. M., Fox, C., Anstee, Q. M., Ness, T., Masson, S., Mathers, J. C., French, J., White, S., et al. (2015) · Clinical Epigenetics · doi:10.1186/s13148-015-0056-6 · Cited by 180
Extracellular Matrix Remodeling in Chronic Liver Disease
Ortiz, C., Schierwagen, R., Schaefer, L., Klein, S., Trepat, X., & Trebicka, J. (2021) · Current Tissue Microenvironment Reports · doi:10.1007/s43152-021-00030-3 · Cited by 177
Toll-like receptors in pathophysiology of liver diseases
Kiziltas, S. (2016) · World Journal of Hepatology · doi:10.4254/wjh.v8.i32.1354 · Cited by 175
Zhao, J., Zhang, Z., Luan, Y., Zou, Z., Sun, Y., Li, Y., Jin, L., Zhou, C., Fu, J., Gao, B., et al. (2014) · Hepatology · doi:10.1002/hep.26916 · Cited by 174
Su, Q., Kim, S. Y., Adewale, F., Zhou, Y., Aldler, C., Ni, M., Wei, Y., Burczynski, M. E., Atwal, G. S., Sleeman, M. W., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103233 · Cited by 149
The Extracellular Matrix: Its Composition, Function, Remodeling, and Role in Tumorigenesis
Dzobo, K., & Dandara, C. (2023) · Biomimetics · doi:10.3390/biomimetics8020146 · Cited by 171
Hepatic neuregulin 4 signaling defines an endocrine checkpoint for steatosis-to-NASH progression
Guo, L., Zhang, P., Chen, Z., Xia, H., Li, S., Zhang, Y., Kobberup, S., Zou, W., & Lin, J. D. (2017) · Journal of Clinical Investigation · doi:10.1172/jci96324 · Cited by 169
Inhibition of Notch Signaling by a γ-Secretase Inhibitor Attenuates Hepatic Fibrosis in Rats
Chen, Y., Zheng, S., Qi, D., Zheng, S., Guo, J., Zhang, S., & Weng, Z. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046512 · Cited by 139
Intercellular crosstalk of hepatic stellate cells in liver fibrosis: New insights into therapy
Cai, X., Wang, J., Wang, J., Zhou, Q., Yang, B., He, Q., & Weng, Q. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104720 · Cited by 166
The perivascular origin of pathological fibroblasts
Di Carlo, S. E., & Peduto, L. (2018) · Journal of Clinical Investigation · doi:10.1172/jci93558 · Cited by 164
Insights into the Epidemiology, Pathogenesis, and Therapeutics of Nonalcoholic Fatty Liver Diseases
Yu, Y., Cai, J., She, Z., & Li, H. (2019) · Advanced Science · doi:10.1002/advs.201801585 · Cited by 164
Chang, C. C., Crane, M., Zhou, J., Mina, M., Post, J. J., Cameron, B. A., Lloyd, A. R., Jaworowski, A., French, M. A., & Lewin, S. R. (2013) · Immunological Reviews · doi:10.1111/imr.12063 · Cited by 163
MicroRNAs, transforming growth factor beta‐1, and tissue fibrosis
Bowen, T., Jenkins, R. H., & Fraser, D. J. (2013) · The Journal of Pathology · doi:10.1002/path.4119 · Cited by 163
Apoptosis and angiogenesis: an evolving mechanism for fibrosis
Johnson, A., & DiPietro, L. A. (2013) · The FASEB Journal · doi:10.1096/fj.12-214189 · Cited by 160
Molecular MRI of collagen to diagnose and stage liver fibrosis
Fuchs, B. C., Wang, H., Yang, Y., Wei, L., Polasek, M., Schühle, D. T., Lauwers, G. Y., Parkar, A., Sinskey, A. J., Tanabe, K. K., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.06.026 · Cited by 160
The spleen in liver cirrhosis: revisiting an old enemy with novel targets
Li, L., Duan, M., Chen, W., Jiang, A., Li, X., Yang, J., & Li, Z. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1214-8 · Cited by 158
Mitophagy-related regulated cell death: molecular mechanisms and disease implications
Yang, M., Wei, X., Yi, X., & Jiang, D. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06804-5 · Cited by 158
The Endothelium as a Driver of Liver Fibrosis and Regeneration
Lafoz, E., Ruart, M., Anton, A., Oncins, A., & Hernández-Gea, V. (2020) · Cells · doi:10.3390/cells9040929 · Cited by 149
“Perpetuation of this “curative” response translates to fibrosis progression, substituting hepatic tissue by a fibrous scar disrupting vascular architecture and liver parenchyma [8,10].”
BackgroundType 3 cytokines IL-17A and IL-22 drive TGF-β–dependent liver fibrosis
Fabre, T., Molina, M. F., Soucy, G., Goulet, J.-P., Willems, B., Villeneuve, J.-P., Bilodeau, M., & Shoukry, N. H. (2018) · Science Immunology · doi:10.1126/sciimmunol.aar7754 · Cited by 155
“Transforming growth factor– (TGF-) signaling is the key fibrogenic signal that activates hepatic stellate cells (HSCs), the main producer of extracellular matrix in the liver, and is modulated by proinflammatory mediators such as cytokines that act on HSCs and liver immune cells (1).”
BackgroundInfluentialThe Role of Innate Immunity in Alcoholic Liver Disease
Nagy, L. (2015) · Alcohol Research: Current Reviews · doi:10.35946/arcr.v37.2.08 · Cited by 151
Fabre, T., Kared, H., Friedman, S. L., & Shoukry, N. H. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400861 · Cited by 150
Self-citationPreisser, L., Miot, C., Guillou‐Guillemette, H., Beaumont, E., Foucher, E. D., Garo, E., Blanchard, S., Frémaux, I., Croué, A., Fouchard, I., et al. (2014) · Hepatology · doi:10.1002/hep.27328 · Cited by 134
A Direct In Vivo RNAi Screen Identifies MKK4 as a Key Regulator of Liver Regeneration
Wuestefeld, T., Pesic, M., Rudalska, R., Dauch, D., Longerich, T., Kang, T.-W., Yevsa, T., Heinzmann, F., Hoenicke, L., Hohmeyer, A., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.026 · Cited by 149
A human multi-lineage hepatic organoid model for liver fibrosis
Guan, Y., Enejder, A., Wang, M., Fang, Z., Cui, L., Chen, S.-Y., Wang, J., Tan, Y., Wu, M., Chen, X., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26410-9 · Cited by 149
Adipocytokines and hepatic fibrosis
Saxena, N. K., & Anania, F. A. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.01.002 · Cited by 135
“1A)—all central actors in the pathogenesis of liver fibrosis [31, 32].”
BackgroundHepatic sinusoids in liver injury, inflammation, and fibrosis: new pathophysiological insights
Greuter, T., & Shah, V. H. (2016) · Journal of Gastroenterology · doi:10.1007/s00535-016-1190-4 · Cited by 148
“allels the extent of injury and fibrosis [88].”
BackgroundChen, L., Zhang, C., Chen, L., Wang, X., Xiang, B., Wu, X., Guo, Y., Mou, X., Yuan, L., Chen, B., et al. (2017) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0265 · Cited by 140
Hepatitis C Virus Induces Interleukin-1β (IL-1β)/IL-18 in Circulatory and Resident Liver Macrophages
Shrivastava, S., Mukherjee, A., Ray, R., & Ray, R. B. (2013) · Journal of Virology · doi:10.1128/jvi.01962-13 · Cited by 136
Immunomodulatory Role of the Extracellular Matrix Within the Liver Disease Microenvironment
McQuitty, C. E., Williams, R., Chokshi, S., & Urbani, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.574276 · Cited by 146
“Generally, liver fibrosis involves increased ECM protein synthesis and deposition, particularly of fibrillar collagens type I, which can be 8-fold higher than in healthy liver (20), collagen type III, fibronectin, and laminin (21) which are deposited in the Space of Disse, forming a dense matrix.”
BackgroundRegulation of hepatic stellate cells by connective tissue growth factor
Huang, G. (2012) · Frontiers in Bioscience · doi:10.2741/4067 · Cited by 135
Metadata
- Authors
- Hernandez-Gea, V., & Friedman, S. L.
- Affiliations
- Division of Liver Diseases, Mount Sinai School of Medicine, New York, New York 10029;
- Icahn School of Medicine at Mount Sinai (US)
- ORCID
- Friedman, Scott L.
- Venue
- Annual Review of Pathology: Mechanisms of Disease
- Publisher
- Annual Reviews
- Published
- 2011-02-28
- Volume
- 6
- Issue
- 1
- Pages
- 425-456
- ISSN
- 1553-4006 (ISSN-L)
- 1553-4014
- OpenAlex
- W2142988890
- Cited by
- 1,809
- References
- 220
- Citations by year
- 2026: 81 · 2025: 123 · 2024: 121 · 2023: 112 · 2022: 148 · 2021: 174 · 2020: 145 · 2019: 119 · 2018: 117 · 2017: 131 · 2016: 136 · 2015: 124 · 2014: 97 · 2013: 76 · 2012: 67
- FWCI
- 10.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annual Review of Pathology Mechanisms of Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Keywords
- liver fibrosis, hepatic stellate cell activation, extracellular matrix, chronic viral hepatitis, hepatic steatosis, obesity, immune signaling, genetic control, fibrosis reversibility, antifibrotic therapy, chronic liver disease
- MeSH terms
- Humans, Liver, Liver Cirrhosis, Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.